Previous 10 | Next 10 |
Invezz news releases related Invezz news releases and Invezz press releases from 12/08/23 10:37:21 on US and Canada Markets.
2023-12-08 10:37:21 ET Altimmune (NASDAQ: ALT) stock proce has staged a strong recovery in the past few days, making it one of the most popular companies among day traders. The shares jumped to a high of $8.63 on Thursday, about 306% above the lowest point this year, giving it a market ...
2023-12-07 18:12:13 ET Broadcom Inc (NASDAQ: AVGO) is in focus in extended trading after reporting market-beating results for its fiscal fourth quarter on strong AI chip demand. Is Broadcom stock worth buying? The semiconductor behemoth now forecasts about $50 billion in revenue...
2023-12-07 17:14:38 ET Lululemon Athletica Inc (NASDAQ: LULU) lost about 7.0% in extended hours even after its reported strong results for its third financial quarter. Why is Lululemon stock down in after-hours? The stock is being punished primarily because the retailer issued d...
2023-12-07 13:39:33 ET Rivian Automotive Inc (NASDAQ: RIVN) has gained close to 25% over the past month but a Stifel analyst is convinced that’s just a drop in the bucket compared to where the stock is headed. Rivian stock could climb to further to $23 Stephen Gengaro ass...
2023-12-07 13:39:33 ET Rivian Automotive Inc (NASDAQ: RIVN) has gained close to 25% over the past month but a Stifel analyst is convinced that’s just a drop in the bucket compared to where the stock is headed. Rivian stock could climb to further to $23 Stephen Gengaro ass...
2023-12-07 13:02:39 ET Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) jumped some 12% today after AbbVie Inc (NYSE: ABBV) said it will buy the drug company that focuses primarily on neurological disorders. AbbVie seems to be on a buying spree AbbVie is willing to spend about $...
2023-12-07 13:02:39 ET Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) jumped some 12% today after AbbVie Inc (NYSE: ABBV) said it will buy the drug company that focuses primarily on neurological disorders. AbbVie seems to be on a buying spree AbbVie is willing to spend about $...
2023-12-07 11:49:46 ET Darren Woods – the Chief Executive of Exxon Mobil Corp (NYSE: XOM) does not expect to face regulatory hurdles in buying Pioneer Natural Resources Co (NYSE: PXD). Woods doesn’t see competition concerns The Federal Trade Commission asked for mo...
2023-12-07 11:49:46 ET Darren Woods – the Chief Executive of Exxon Mobil Corp (NYSE: XOM) does not expect to face regulatory hurdles in buying Pioneer Natural Resources Co (NYSE: PXD). Woods doesn’t see competition concerns The Federal Trade Commission asked for mo...
2023-12-07 10:54:07 ET Bitcoin has massively outperformed JPMorgan stock on any given timeframe, says Michael Novogratz. He’s the Chief Executive of Galaxy Investment Partners. Novogratz continues to favour BTC His comment arrives just a day after the bank’s top bo...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
20.92%Change Percent:
Snap Inc. Class A Company Name:
SNAP Stock Symbol:
NYSE Market:
snap.com Website: